Rich Priore Believes Investing in Public Health Can Bring Things Around Once PHE Expires
Rich Priore, Sc.D., M.H.A., a clinical associate professor in the Department of Health Policy and Management at Tulane University, said if Americans invested in health prevention and wellness, fewer would be in hospitals and the cost of care would lower.
Rich Priore, Sc.D., M.H.A., a clinical associate professor in the Department of Health Policy and Management at Tulane University, expressed that if Americans invest in health prevention and wellness, less would be in hospitals and the cost of care would lower.
When asked if he agrees with President Biden on declaring the expiration of the COVID-19 Public Health Emergency, Priore said he did from a financial standpoint. According to the Peter G. Peterson Foundation, the country is $31 trillion in debt. The country is running out of capital and the Biden administration doesn't have the ability to continue funding the PHE any longer. However, hospitals and patients will be suffering the most.
Hospitals will need more funding eventually as the COVID crisis continues and those with chronic conditions continue to be at risk today, he said. If more Americans can invest in public health, more than money will be saved in the end.
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Insights Into Chronic Itch From Shawn Kwatra, M.D.
April 15th 2025A Q&A between Shawn Kwatra, M.D., professor and chair of dermatology at the University of Maryland School of Medicine, and Managed Healthcare Executive about new discoveries in chronic itch, how treatment options are improving and the challenges patients face in getting access to the right therapies.
Read More
